person

Szymon K.

Country
Poland
Department
Klinika Kardiochirurgii

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 18 partner sites.

Specializations

Coronary Artery Disease & Acute Coronary Syndromes

The investigator concentrates on the pathophysiology, interventional management, and postoperative outcomes of Acute Coronary Syndrome and related coronary artery disease.

  • ST-Elevation Myocardial Infarction
  • Non-ST-Elevation Myocardial Infarction
  • Percutaneous Coronary Intervention
  • Coronary artery bypass grafting

Emphasis is placed on reducing myocardial injury and enhancing graft durability.

Heart Failure Phenotypes

Research targets both reduced and preserved ejection fraction forms of Heart Failure, including associated cardiogenic shock states.

  • Heart Failure with Reduced Ejection Fraction (HFrEF)
  • Heart Failure with Preserved Ejection Fraction (HFpEF)
  • Cardiogenic Shock
  • Left Ventricular Hypertrophy

Goals include optimizing hemodynamic support and mitigating progression.

Atrial Fibrillation & Stroke Prevention

The focus encompasses rhythm management, anticoagulation strategies, and embolic risk reduction in patients with Atrial Fibrillation.

  • Non-valvular Atrial Fibrillation
  • Stroke and Systemic Embolism
  • Anticoagulant therapy suitability
  • Post‑operative atrial arrhythmias

Investigations aim to balance thrombotic protection with bleeding risk.

Metabolic and Renal Interactions

Exploration of how obesity, diabetes, and chronic kidney disease intersect with cardiovascular pathology.

  • Obesity‑related Atherosclerotic Cardiovascular Disease
  • Type 2 Diabetes Mellitus
  • Chronic Kidney Disease (CKD)
  • Hypertension

Efforts target integrated risk modification and organ‑protective strategies.

Pulmonary Hypertension & Cardio‑Pulmonary Syndromes

Investigation of elevated pulmonary pressures arising from left‑heart disease and idiopathic mechanisms.

  • Group 2 Pulmonary Hypertension
  • Pulmonary Arterial Hypertension
  • Idiopathic Pulmonary Fibrosis
  • Systemic Sclerosis‑Associated Interstitial Lung Disease

Research seeks to improve functional capacity and survival outcomes.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.